Literature DB >> 30385504

Conjugation of urate-derived electrophiles to proteins during normal metabolism and inflammation.

Rufus Turner1,2, Stephen O Brennan2, Louisa V Ashby1,2, Nina Dickerhof1,2, Melanie R Hamzah1,2, John F Pearson3, Lisa K Stamp4, Anthony J Kettle5,2.   

Abstract

Urate is often viewed as an antioxidant. Here, we present an alternative perspective by showing that, when oxidized, urate propagates oxidative stress. Oxidation converts urate to the urate radical and the electrophilic products dehydrourate, 5-hydroxyisourate, and urate hydroperoxide, which eventually break down to allantoin. We investigated whether urate-derived electrophiles are intercepted by nucleophilic amino acid residues to form stable adducts on proteins. When urate was oxidized in the presence of various peptides and proteins, two adducts derived from urate (M r 167 Da) were detected and had mass additions of 140 and 166 Da, occurring mainly on lysine residues and N-terminal amines. The adduct with a 140-Da mass addition was detected more frequently and was stable. Dehydrourate (M r 166 Da) also formed transient adducts with cysteine residues. Urate-derived adducts were detected on human serum albumin in plasma of healthy donors. Basal adduct levels increased when neutrophils were added to plasma and stimulated, and relied on the NADPH oxidase, myeloperoxidase, hydrogen peroxide, and superoxide. Adducts of oxidized urate on serum albumin were elevated in plasma and synovial fluid from individuals with gout and rheumatoid arthritis. We propose that rather than acting as an antioxidant, urate's conversion to electrophiles contributes to oxidative stress. The addition of urate-derived electrophiles to nucleophilic amino acid residues, a process we call oxidative uratylation, will leave a footprint on proteins that could alter their function when critical sites are modified.
© 2018 Turner et al.

Entities:  

Keywords:  NADPH oxidase; biomarker; lysine modification; myeloperoxidase; neutrophil; oxidative stress; post-translational modification (PTM); protein adduct; uratylation; uric acid

Mesh:

Substances:

Year:  2018        PMID: 30385504      PMCID: PMC6314113          DOI: 10.1074/jbc.RA118.005237

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  Spectral and kinetic evidence for reaction of superoxide with compound I of myeloperoxidase.

Authors:  Anthony J Kettle; Andrej Maroz; Grant Woodroffe; Christine C Winterbourn; Robert F Anderson
Journal:  Free Radic Biol Med       Date:  2011-09-25       Impact factor: 7.376

2.  2-thioxanthines are mechanism-based inactivators of myeloperoxidase that block oxidative stress during inflammation.

Authors:  Anna-Karin Tidén; Tove Sjögren; Mats Svensson; Alexandra Bernlind; Revathy Senthilmohan; Francoise Auchère; Henrietta Norman; Per-Olof Markgren; Susanne Gustavsson; Staffan Schmidt; Stefan Lundquist; Louisa V Forbes; Nicholas J Magon; Louise N Paton; Guy N L Jameson; Håkan Eriksson; Anthony J Kettle
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

3.  Oxidized glutathione and uric acid as biomarkers of early cystic fibrosis lung disease.

Authors:  Nina Dickerhof; Rufus Turner; Irada Khalilova; Emmanuelle Fantino; Peter D Sly; Anthony J Kettle
Journal:  J Cyst Fibros       Date:  2016-11-24       Impact factor: 5.482

4.  On-line mass spectrometric investigation of the peroxidase-catalysed oxidation of uric acid.

Authors:  K J Volk; R A Yost; A Brajter-Toth
Journal:  J Pharm Biomed Anal       Date:  1990       Impact factor: 3.935

Review 5.  Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?

Authors:  Zohreh Soltani; Kashaf Rasheed; Daniel R Kapusta; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

6.  Uric acid: the oxidant-antioxidant paradox.

Authors:  Yuri Y Sautin; Richard J Johnson
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2008-06       Impact factor: 1.381

Review 7.  Uric acid in metabolic syndrome: From an innocent bystander to a central player.

Authors:  Mehmet Kanbay; Thomas Jensen; Yalcin Solak; Myphuong Le; Carlos Roncal-Jimenez; Chris Rivard; Miguel A Lanaspa; Takahiko Nakagawa; Richard J Johnson
Journal:  Eur J Intern Med       Date:  2015-12-15       Impact factor: 4.487

8.  Oxidation of hydroquinone by myeloperoxidase. Mechanism of stimulation by benzoquinone.

Authors:  A J Kettle; C C Winterbourn
Journal:  J Biol Chem       Date:  1992-04-25       Impact factor: 5.157

9.  Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.

Authors:  B N Ames; R Cathcart; E Schwiers; P Hochstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

10.  Kinetics of fusion of the cytoplasmic granules with phagocytic vacuoles in human polymorphonuclear leukocytes. Biochemical and morphological studies.

Authors:  A W Segal; J Dorling; S Coade
Journal:  J Cell Biol       Date:  1980-04       Impact factor: 10.539

View more
  3 in total

1.  Uric Acid Reacts with Peroxidasin, Decreases Collagen IV Crosslink, Impairs Human Endothelial Cell Migration and Adhesion.

Authors:  Bianca Dempsey; Litiele Cezar Cruz; Marcela Franco Mineiro; Railmara Pereira da Silva; Flavia Carla Meotti
Journal:  Antioxidants (Basel)       Date:  2022-06-04

2.  Myeloperoxidase and related biomarkers are suggestive footprints of endothelial microvascular inflammation in HFpEF patients.

Authors:  Camilla Hage; Erik Michaëlsson; Bengt Kull; Tasso Miliotis; Sara Svedlund; Cecilia Linde; Erwan Donal; Jean-Claude Daubert; Li-Ming Gan; Lars H Lund
Journal:  ESC Heart Fail       Date:  2020-05-19

3.  Image- and Fluorescence-Based Test Shows Oxidant-Dependent Damages in Red Blood Cells and Enables Screening of Potential Protective Molecules.

Authors:  Manon Bardyn; Jérôme Allard; David Crettaz; Benjamin Rappaz; Gerardo Turcatti; Jean-Daniel Tissot; Michel Prudent
Journal:  Int J Mol Sci       Date:  2021-04-20       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.